These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11727203)

  • 1. [Efficacy and tolerance of gabapentin in dystonia and hemifacial spasm: a pilot study].
    Linazasoro Cristóbal G
    Rev Neurol; 2001 Sep 1-15; 33(5):408-10. PubMed ID: 11727203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gabapentin in the treatment of hemifacial spasm.
    Daniele O; Caravaglios G; Marchini C; Mucchiut L; Capus P; Natalè E
    Acta Neurol Scand; 2001 Aug; 104(2):110-2. PubMed ID: 11493229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gabapentin as treatment for hemifacial spasm.
    Bandini F; Mazzella L
    Eur Neurol; 1999 Jul; 42(1):49-51. PubMed ID: 10394048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
    Bihari K
    Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gabapentin for the treatment of hemifacial spasm.
    Patel J; Naritoku DK
    Clin Neuropharmacol; 1996 Apr; 19(2):185-8. PubMed ID: 8777773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group.
    Berardelli A; Formica A; Mercuri B; Abbruzzese G; Agnoli A; Agostino R; Caraceni T; Carella F; De Fazio G; De Grandis D
    Ital J Neurol Sci; 1993 Jun; 14(5):361-7. PubMed ID: 8354632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin for neurological disorders in a movement disorders clinic in Singapore.
    Tan AK
    Singapore Med J; 1998 Sep; 39(9):403-5. PubMed ID: 9885719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gabapentin for familial paroxysmal dystonic choreoathetosis.
    Chudnow RS; Mimbela RA; Owen DB; Roach ES
    Neurology; 1997 Nov; 49(5):1441-2. PubMed ID: 9371936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Botulinum toxin therapy for focal dystonia].
    Hahn K; Niklai E; Garzuly F; Szupera Z
    Orv Hetil; 2009 Jul; 150(29):1381-4. PubMed ID: 19581172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gabapentin decreases the severity of dystonia at low doses in a genetic animal model of paroxysmal dystonic choreoathetosis.
    Richter A; Löscher W
    Eur J Pharmacol; 1999 Mar; 369(3):335-8. PubMed ID: 10225372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.
    Brin MF; Fahn S; Moskowitz C; Friedman A; Shale HM; Greene PE; Blitzer A; List T; Lange D; Lovelace RE
    Mov Disord; 1987; 2(4):237-54. PubMed ID: 3504553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin as a treatment for blepharospasm, spasmodic torticollis and hemifacial spasm.
    Albanese A; Colosimo C; Carretta D; Dickmann A; Bentivoglio AR; Tonali P
    Eur Neurol; 1992; 32(2):112-7. PubMed ID: 1563461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dystonia in a patient treated with propranolol and gabapentin.
    Palomeras E; Sanz P; Cano A; Fossas P
    Arch Neurol; 2000 Apr; 57(4):570-1. PubMed ID: 10768633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH; Cetinkaya A; Kulwin DR
    Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind controlled trial of gabapentin in essential tremor.
    Pahwa R; Lyons K; Hubble JP; Busenbark K; Rienerth JD; Pahwa A; Koller WC
    Mov Disord; 1998 May; 13(3):465-7. PubMed ID: 9613738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tremor associated with benign IgM paraproteinaemic neuropathy successfully treated with gabapentin.
    Saverino A; Solaro C; Capello E; Trompetto C; Abbruzzese G; Schenone A
    Mov Disord; 2001 Sep; 16(5):967-8. PubMed ID: 11746634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of ataxia in cortical cerebellar atrophy with the GABAergic drug gabapentin. A preliminary study.
    Gazulla J; Errea JM; Benavente I; Tordesillas CJ
    Eur Neurol; 2004; 52(1):7-11. PubMed ID: 15218338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gabapentin for parkinsonism: a double-blind, placebo-controlled, crossover trial.
    Olson WL; Gruenthal M; Mueller ME; Olson WH
    Am J Med; 1997 Jan; 102(1):60-6. PubMed ID: 9209202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gabapentin and motor fluctuations in Parkinson's disease.
    Chaná P; de Marinis A; Barrientos N
    Mov Disord; 1997 Jul; 12(4):608. PubMed ID: 9251083
    [No Abstract]   [Full Text] [Related]  

  • 20. Costs of treating dystonias and hemifacial spasm with botulinum toxin A.
    Dodel RC; Kirchner A; Koehne-Volland R; Künig G; Ceballos-Baumann A; Naumann M; Brashear A; Richter HP; Szucs TD; Oertel WH
    Pharmacoeconomics; 1997 Dec; 12(6):695-706. PubMed ID: 10175981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.